Early response to haloperidol treatment in chronic schizophrenia

Robert G. Stern, RenéS Kahn, Philip D Harvey, Farooq Amin, Seth H. Apter, Jack Hirschowitz

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

This study examined the time-course of treatment response to haloperidol in chronic schizophrenia. Furthermore the predictive value of baseline psychopathology and early therapeutic changes for the identification of the eventual treatment outcome was examined. After a two-week drug-free period forty-three chronic schizophrenic patients were treated with haloperidol for five weeks. Psychopathology was assessed on the last drug-free day and on the third and eighth day from the initiation of treatment, and then at weekly intervals. At the end of the study based on a priori criteria patients were classified as responders or non-responders to haloperidol. Seventeen patients met criteria for treatment response at the end of five weeks of treatment, while 26 did not. Already by the third day of treatment, in the responders there was a significant decrease in total BPRS and in the subscales scores for psychosis, tension and anergia, but not for hostility-suspiciousness and depression. These decreases represented approximately half of the eventual improvement obtained by the end of the study. Discriminant function analysis showed that severity of symptoms at baseline and improvement by day 3 correctly classified overall outcome in 72% of the cases.

Original languageEnglish
Pages (from-to)165-171
Number of pages7
JournalSchizophrenia Research
Volume10
Issue number2
DOIs
StatePublished - Jan 1 1993
Externally publishedYes

Fingerprint

Haloperidol
Schizophrenia
Psychopathology
Therapeutics
Hostility
Discriminant Analysis
Pharmaceutical Preparations
Psychotic Disorders
Depression

Keywords

  • (Schizophrenia)
  • Early treatment response
  • Haloperidol
  • Response prediction

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Behavioral Neuroscience
  • Biological Psychiatry
  • Neurology
  • Psychology(all)

Cite this

Early response to haloperidol treatment in chronic schizophrenia. / Stern, Robert G.; Kahn, RenéS; Harvey, Philip D; Amin, Farooq; Apter, Seth H.; Hirschowitz, Jack.

In: Schizophrenia Research, Vol. 10, No. 2, 01.01.1993, p. 165-171.

Research output: Contribution to journalArticle

Stern, RG, Kahn, R, Harvey, PD, Amin, F, Apter, SH & Hirschowitz, J 1993, 'Early response to haloperidol treatment in chronic schizophrenia', Schizophrenia Research, vol. 10, no. 2, pp. 165-171. https://doi.org/10.1016/0920-9964(93)90052-K
Stern, Robert G. ; Kahn, RenéS ; Harvey, Philip D ; Amin, Farooq ; Apter, Seth H. ; Hirschowitz, Jack. / Early response to haloperidol treatment in chronic schizophrenia. In: Schizophrenia Research. 1993 ; Vol. 10, No. 2. pp. 165-171.
@article{95a0fbda08e94aef84f83e84deb15853,
title = "Early response to haloperidol treatment in chronic schizophrenia",
abstract = "This study examined the time-course of treatment response to haloperidol in chronic schizophrenia. Furthermore the predictive value of baseline psychopathology and early therapeutic changes for the identification of the eventual treatment outcome was examined. After a two-week drug-free period forty-three chronic schizophrenic patients were treated with haloperidol for five weeks. Psychopathology was assessed on the last drug-free day and on the third and eighth day from the initiation of treatment, and then at weekly intervals. At the end of the study based on a priori criteria patients were classified as responders or non-responders to haloperidol. Seventeen patients met criteria for treatment response at the end of five weeks of treatment, while 26 did not. Already by the third day of treatment, in the responders there was a significant decrease in total BPRS and in the subscales scores for psychosis, tension and anergia, but not for hostility-suspiciousness and depression. These decreases represented approximately half of the eventual improvement obtained by the end of the study. Discriminant function analysis showed that severity of symptoms at baseline and improvement by day 3 correctly classified overall outcome in 72{\%} of the cases.",
keywords = "(Schizophrenia), Early treatment response, Haloperidol, Response prediction",
author = "Stern, {Robert G.} and Ren{\'e}S Kahn and Harvey, {Philip D} and Farooq Amin and Apter, {Seth H.} and Jack Hirschowitz",
year = "1993",
month = "1",
day = "1",
doi = "10.1016/0920-9964(93)90052-K",
language = "English",
volume = "10",
pages = "165--171",
journal = "Schizophrenia Research",
issn = "0920-9964",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Early response to haloperidol treatment in chronic schizophrenia

AU - Stern, Robert G.

AU - Kahn, RenéS

AU - Harvey, Philip D

AU - Amin, Farooq

AU - Apter, Seth H.

AU - Hirschowitz, Jack

PY - 1993/1/1

Y1 - 1993/1/1

N2 - This study examined the time-course of treatment response to haloperidol in chronic schizophrenia. Furthermore the predictive value of baseline psychopathology and early therapeutic changes for the identification of the eventual treatment outcome was examined. After a two-week drug-free period forty-three chronic schizophrenic patients were treated with haloperidol for five weeks. Psychopathology was assessed on the last drug-free day and on the third and eighth day from the initiation of treatment, and then at weekly intervals. At the end of the study based on a priori criteria patients were classified as responders or non-responders to haloperidol. Seventeen patients met criteria for treatment response at the end of five weeks of treatment, while 26 did not. Already by the third day of treatment, in the responders there was a significant decrease in total BPRS and in the subscales scores for psychosis, tension and anergia, but not for hostility-suspiciousness and depression. These decreases represented approximately half of the eventual improvement obtained by the end of the study. Discriminant function analysis showed that severity of symptoms at baseline and improvement by day 3 correctly classified overall outcome in 72% of the cases.

AB - This study examined the time-course of treatment response to haloperidol in chronic schizophrenia. Furthermore the predictive value of baseline psychopathology and early therapeutic changes for the identification of the eventual treatment outcome was examined. After a two-week drug-free period forty-three chronic schizophrenic patients were treated with haloperidol for five weeks. Psychopathology was assessed on the last drug-free day and on the third and eighth day from the initiation of treatment, and then at weekly intervals. At the end of the study based on a priori criteria patients were classified as responders or non-responders to haloperidol. Seventeen patients met criteria for treatment response at the end of five weeks of treatment, while 26 did not. Already by the third day of treatment, in the responders there was a significant decrease in total BPRS and in the subscales scores for psychosis, tension and anergia, but not for hostility-suspiciousness and depression. These decreases represented approximately half of the eventual improvement obtained by the end of the study. Discriminant function analysis showed that severity of symptoms at baseline and improvement by day 3 correctly classified overall outcome in 72% of the cases.

KW - (Schizophrenia)

KW - Early treatment response

KW - Haloperidol

KW - Response prediction

UR - http://www.scopus.com/inward/record.url?scp=0027194208&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027194208&partnerID=8YFLogxK

U2 - 10.1016/0920-9964(93)90052-K

DO - 10.1016/0920-9964(93)90052-K

M3 - Article

VL - 10

SP - 165

EP - 171

JO - Schizophrenia Research

JF - Schizophrenia Research

SN - 0920-9964

IS - 2

ER -